TY  - JOUR
T1  - Relationship between Pre-Existing Conditions in Covid-19 Patients and Inflammation
A1  - Luminita Fritea
A1  - Maruzella Sipponen
A1  - Angela Antonescu
A1  - Florina Groza Miere
A1  - Razvan Chirla
A1  - Cosmin Vesa
A1  - Simona Cavalu
A1  - Mariana Ganea
A1  - Tunde Horvath
A1  - Codruta Petchesi
A1  - Maria Domuta
JF  - Pharmacophore
JO  - Pharmacophore
SN  - 2229-5402
Y1  - 2022
VL  - 13
IS  - 4
DO  - 10.51847/VsOsr2f5dN
SP  - 41
EP  - 48
N2  - COVID-19 is characterized by a strong inflammatory response leading to specific changes in the immune system cell counts. In this study, the following biomarkers from the laboratory data of COVID-19 patients have been analyzed: white blood cells (WBC), neutrophils, lymphocytes, monocytes, eosinophils, basophils, C-reactive protein, and glycemia. Various comparisons, correlations, and ratios between these inflammatory biomarkers have been performed to assess the link between pre-existing conditions and the various blood markers, as well as the disease severity. WBC, neutrophils, C-reactive protein, and glycemia had high levels in more than 60-70% of the patients, although diabetic patients had even higher glycemia levels (p
UR  - https://pharmacophorejournal.com/article/relationship-between-pre-existing-conditions-in-covid-19-patients-and-inflammation-qkl7m4jrnlrfvnb
ER  -